Abstract

Mild parkinsonian signs (MPS) have been widely studied during the past 3 decades and proposed as a risk marker for neurodegenerative disease. This systematic review explores the epidemiology, clinical and prognostic associations, radiological features, and pathological findings associated with MPS in older adults free from neurodegenerative disease. We find that MPS as currently defined are strongly associated with increasing age and increased risk of development of Parkinson's disease (PD), all-cause dementia, disability, and death. Positive associations with later PD are found mainly in younger populations and those with other features of prodromal PD. There are currently no consistent radiological findings for MPS, and pathological studies have shown that MPS, at least in the oldest old, are often underpinned by mixed neuropathologies, including those associated with Alzheimer's disease, cerebrovascular disease, nigral neuronal loss, and Lewy bodies. Different subcategories of MPS appear to convey varying risk and specificity for PD and other outcomes. MPS overall are not specific for parkinsonian disorders and, although associated with increased risk of PD, can reflect multiple pathologies, particularly in older individuals. "Mild motor signs" appears a more appropriate term to avoid prognostic and pathological implications, and larger future studies to prospectively examine outcomes and associations of specific MPS subcategories are required. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Highlights

  • A follow-up of this study found that the microtubule-associated protein tau gene (MAPT) H2 haplotype associated with Mild parkinsonian signs (MPS), the potential mechanism of action is unclear.[104]

  • MPS occur in the prodrome of Parkinson’s disease (PD) before a diagnosis of PD can be made, and their presence has been associated with an increased risk of later diagnosis of PD and with reduced dopamine transporter imaging

  • We suggest that where the aim is to use MPS to determine groups at risk of particular outcomes, for example, for PD, for trials of preventive or modifying interventions, there is a need to do the following: 1. Form consistent definitions of MPS and its subcategories to increase comparability across studies

Read more

Summary

Methods

This systematic review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses[2] reporting guidelines. The search strategy was designed to detect peerreviewed journal articles that included examination of MPS in adults without neurodegenerative disease using clear criteria distinguishing these individuals from those with other known causes of parkinsonism. Study Types Articles of the following types were included: 1. Descriptive studies of the prevalence, incidence, and associations of MPS from cohort and case-control studies of community-based older adults. 2. Cohort or case-control studies investigating the imaging features of MPS. 3. Cohort or case-control studies investigating the pathological features of MPS. Studies lacking a clear definition of MPS distinguishing them from other causes of parkinsonism

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call